The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Arjan Lalchandani
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Arjan Lalchandani, Promoter and Managing Director of Dr Lalchandani Labs Ltd, sold 76,000 equity shares through open market between August 22 and August 29, 2025. The sale represents 1.75% of the company's total share/voting capital. His holding fell from 12,26,851 shares (28.31%) to 11,50,851 shares (26.56%) post-sale. The disclosure was filed under Regulation 29(2) of SEBI's Takeover Regulations, 2011, and the mode of sale was open market.
A modest promoter offload of 1.75% via open market; holdings still well below the 50% mark. Retail investors may view this as a mild negative signal, though the stake remains substantial at 26.56%.